Century Therapeutics Files Annual Report
Ticker: IPSC · Form: ARS · Filed: Apr 16, 2026
Sentiment: neutral
Topics: annual-report, security-holders, filing
TL;DR
Century Therapeutics filed its 2025 ARS on 4/16/26. Check it for performance details.
AI Summary
Century Therapeutics, Inc. filed an Annual Report to Security Holders (ARS) on April 16, 2026, for the period ending December 31, 2025. The company is based in Philadelphia, PA, and operates in the Biological Products sector. The filing includes a complete submission text file and a PDF document.
Why It Matters
This filing provides shareholders with an overview of the company's performance and financial standing for the fiscal year 2025.
Risk Assessment
Risk Level: low — This is a routine annual filing and does not indicate any immediate or specific risks.
Key Players & Entities
- Century Therapeutics, Inc. (company) — Filer of the ARS
- 2025-12-31 (date) — Period of Report
- 2026-04-16 (date) — Filing Date
- PHILADELPHIA (location) — Company Mailing and Business Address
FAQ
What type of filing is this?
This is an Annual Report to Security Holders (ARS) filing.
When was this filing submitted?
The filing was accepted on April 16, 2026.
What period does this report cover?
The period of report is December 31, 2025.
Where is Century Therapeutics, Inc. located?
The company's mailing and business address is 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104.
What is the SIC code for Century Therapeutics, Inc.?
The SIC code is 2836 for Biological Products, (No Diagnostic Substances).
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 16, 2026 regarding Century Therapeutics, Inc. (IPSC).